Anne Donnelly
Overview
Explore the profile of Anne Donnelly including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
22
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Serbin M, Marras C, Mansfield C, Leach C, Yonan C, Sheehan M, et al.
Patient Prefer Adherence
. 2023 Sep;
17:2263-2277.
PMID: 37724313
Background: Several adjunctive medications are available to reduce OFF time between levodopa/carbidopa (LD/CD) doses for people with Parkinson's disease (PD). Objective: To explore how individuals with PD balance benefits and...
2.
Tervonen T, Veldwijk J, Payne K, Ng X, Levitan B, Lackey L, et al.
Value Health
. 2023 Apr;
26(4):449-460.
PMID: 37005055
Benefit-risk assessment is commonly conducted by drug and medical device developers and regulators, to evaluate and communicate issues around benefit-risk balance of medical products. Quantitative benefit-risk assessment (qBRA) is a...
3.
Chaudhuri S, Ben Chaouch Z, Hauber B, Mange B, Zhou M, Christopher S, et al.
J Biopharm Stat
. 2023 Mar;
:1-20.
PMID: 36861942
A fixed one-sided significance level of 5% is commonly used to interpret the statistical significance of randomized clinical trial (RCT) outcomes. While it is necessary to reduce the false positive...
4.
Benz H, Caldwell B, Ruiz J, Saha A, Ho M, Christopher S, et al.
MDM Policy Pract
. 2021 Jul;
6(1):23814683211021380.
PMID: 34277950
A growing literature has developed on identifying outcomes that matter to patients. This study demonstrates an approach involving patient and regulatory perspectives to identify outcomes that are meaningful in the...
5.
Hauber B, Mange B, Zhou M, Chaudhuri S, Benz H, Caldwell B, et al.
MDM Policy Pract
. 2021 Feb;
6(1):2381468320978407.
PMID: 33521289
Parkinson's disease (PD) is neurodegenerative, causing motor, cognitive, psychological, somatic, and autonomic symptoms. Understanding PD patients' preferences for novel neurostimulation devices may help ensure that devices are delivered in a...
6.